Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
 
Skip navigation

A study to find the best way to give radiotherapy for people with small cell lung cancer (CONVERT)

This study is looking at whether it is best to have radiotherapy once or twice a day, when you are also having cisplatin and etoposide chemotherapy. This trial is supported by Cancer Research UK.

Doctors usually treat small cell lung cancer with a combination of chemotherapy and radiotherapy. We know from research that having both treatments can control small cell lung cancer for longer. There are different ways of having this treatment. Some people have radiotherapy and chemotherapy at the same time. Others have one treatment after the other. Some people have lung radiotherapy twice a day, others once a day.

Doctors want to find the best way to combine radiotherapy with chemotherapy. In this trial they will look for the best dose of radiation to give, and how many days to split the treatment into. The aims of this trial are to find out

  • The best total dose of radiotherapy to give
  • Whether radiotherapy once or twice a day works best

Recruitment

Start 07/04/2008
End 31/05/2013

Phase

Phase 3

Who can enter

You can enter this trial if you

You cannot enter this trial if you

  • Have had any cancer except carcinoma in situ of the cervix, non melanoma skin cancer or another cancer (except breast cancer) that was removed and has been clear for at least 5 years
  • Have already had surgery for lung cancer
  • Have already had radiotherapy for lung cancer
  • Have fluid around your heart or lungs (pericardial or pleural effusions) caused by your cancer
  • Have any other serious illness that may affect the results of the trial
  • Are pregnant or breastfeeding

Trial design

This trial will recruit 532 patients over 4 years. This is a randomised trial. The people taking part are put into treatment groups by a computer. Neither you nor your doctor will be able to decide which group you are in.

Everyone in the trial will have cisplatin and etoposide chemotherapy. These are standard chemotherapy drugs for small cell lung cancer. You will have your chemotherapy through a drip into a vein, on the first 3 days of every 3 week cycle of treatment. You will have up to 6 cycles of chemotherapy altogether. You will begin radiotherapy 3 weeks after your first cycle of chemotherapy. You can talk to your doctor more about your chemotherapy.

If you are in group 1, you will have radiotherapy twice a day, Monday to Friday, for 3 weeks. You will have a gap of around 6 to 8 hours between your treatments each day. The radiotherapy itself will take about 15 minutes per treatment.

If you are in group 2, you will have radiotherapy once a day, Monday to Friday, for 6 and a half weeks.

The research team will also ask for your permission (consent) to store a sample of cancer tissue removed during your surgery, and some extra blood samples. This tissue and blood will be used in future research into small cell lung cancer. You will have the extra blood samples taken at the same time as other blood tests.

After you have completed the radiotherapy and chemotherapy to your chest, your doctor may offer you a short course of radiotherapy to your brain. This is to help prevent your lung cancer spreading to your brain. If your doctor thinks this is appropriate for you they will explain more about this treatment.

Hospital visits

Before you start the trial, you will see the doctor and have some tests. These tests include

Everyone will have between 4 and 6 cycles of chemotherapy, depending on what their doctor has prescribed. So your chemotherapy could last between 12 and 18 weeks. You will have your chemotherapy and radiotherapy as an outpatient.

Before each cycle of chemotherapy, you will see the doctor and have a blood test. As part of the trial, you will also have a chest X-ray before your first cycle of chemotherapy, and before alternate cycles after this.

If you are in group 1, you will start your course of radiotherapy on the first day of your second cycle of chemotherapy. Your radiotherapy will last for 3 weeks. You will then have more chemotherapy every 3 weeks until you have finished your course.

If you are in group 2, you will also start your radiotherapy at the same time as your second cycle of chemotherapy. Your radiotherapy will continue for 6 and a half weeks. You will continue to have your remaining cycles of chemotherapy during this time.

During your radiotherapy, you will see the doctor weekly for a check up while you are in for your treatment. You will have a CT scan when you finish your treatment, and 6 months later. You will also see the trial team every week after the study until any symptoms have cleared up. You will then see the team every

  • 3 months for one year
  • 6 months after this

After the trial has finished, you will continue to see you own doctor as you did before.

Side effects

Common side effects of cisplatin and etoposide chemotherapy include

You can find out more about cisplatin and etoposide chemotherapy on CancerHelp UK.

Common short term side effects of radiotherapy include

Possible late (delayed) side effects of radiotherapy for lung cancer include

You may have a small bruise where you had your blood test.

Location of trial

For more information

Please note: we cannot help you to join a specific trial. Unless we state otherwise in this trial summary, you need to print this page and take it to your own doctor to discuss.

Find out how to join a trial or contact our cancer information nurses for other questions about cancer by phone (0808 800 4040), by email, or at

The Information Nurses
Cancer Research UK
Angel Building
407 St John Street
London
EC1V 4AD

Chief Investigator

Dr Corinne Faivre-Finn

This is Cancer Research UK trial number CRUK/07/005.

Supported by

Cancer Research UK
European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
French Lung Cancer Group (GFPC)
National Cancer Institute of Canada
National Institute for Health Research Cancer Research Network (NCRN)
Spanish Lung Cancer Group (GECP)
The Christie NHS Foundation Trust
Rate this page:
Submit rating
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Send feedback
Question about cancer? Contact our information nurse team